Myogenesis is the process by which muscle tissue is formed during embryonic development and throughout postnatal life. It involves a series of coordinated events, including the specification of muscle precursor cells, their proliferation, migration, differentiation, and fusion to form multinucleated myotubes, which ultimately mature into functional muscle fibres. During embryonic development, myogenesis begins with the specification of mesodermal cells in the somites to become myogenic precursor cells, known as myoblasts. These myoblasts express specific transcription factors, such as MyoD, Myf5, Myogenin, and MRF4, which regulate their commitment to the muscle lineage and initiate the expression of muscle-specific genes. As development progresses, myoblasts proliferate and migrate to their final destinations within the embryo, guided by various signalling molecules and cell-cell interactions. Upon reaching their target locations, myoblasts exit the cell cycle and undergo terminal differentiation, characterized by the expression of contractile proteins such as myosin and actin, and the formation of sarcomeres—the basic functional units of muscle contraction. In summary, myogenesis is a complex and tightly regulated process that governs the formation, growth, and regeneration of muscle tissue. By unraveling the molecular and cellular mechanisms underlying myogenesis, researchers can gain insights into muscle development and function and develop new strategies for treating muscle-related disorders and promoting musculoskeletal health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States